BioCentury | Mar 10, 2014
Company News

diaDexus, Thermo Fisher deal

...risk prediction and prognosis for heart failure. The biomarkers are midregional pro adrenomedullin (MR-proADM) , midregional pro atrial natriuretic peptide (MR-proANP)...
BioCentury | Jul 25, 2011
Company News

Alere, Thermo Fisher deal

...PCT) for the early detection of sepsis in critically ill patients, and Copeptin, MR-proADM and MR-proANP...
Items per page:
1 - 2 of 2